PRECIXAN
Live / Registered — Registered (as of 21 Nov 2023)
What this means for you
Registered since 21 Nov 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 21 Nov 2029: the §8 declaration of use).
Record
- Serial number
- 97297477
- Registration number
- 7226029
- Mark type
- Word mark
- Filed
- 05 Mar 2022
- Published for opposition
- 24 Jan 2023
- Registered
- 21 Nov 2023
- Next maintenance filing
- §8 declaration of use, due by 21 Nov 2029 (grace period to 21 May 2030)
- Attorney of record
- KEVIN O'KEEFE
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of cancer diseases, cacinoma diseases, malignant diseases, infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for musculo-skeletal disorders, cancer diseases, cacinoma diseases, and malignant diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Tumor suppressing agents
Owner
- Shanghai Affinity Biopharmaceutical Co.,Ltd., Shanghai, CN
- Shanghai Affinity Biopharmaceutical Co.,Ltd., Shanghai, CN
- Shanghai Affinity Biopharmaceutical Co.,Ltd., Shanghai, CN
Prosecution history
- 21 Nov 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Nov 2023 — REGISTERED-PRINCIPAL REGISTER
- 19 Oct 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Oct 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Sept 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Aug 2023 — USE AMENDMENT FILED
- 08 Sept 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Aug 2023 — TEAS STATEMENT OF USE RECEIVED
- 21 Mar 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Jan 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Jan 2023 — PUBLISHED FOR OPPOSITION
- 04 Jan 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Dec 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Dec 2022 — ASSIGNED TO EXAMINER
- 09 Mar 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED